Privia Health Group, Inc. PRVA R2K

Healthcare · Health Information Services · United States

https://www.priviahealth.com

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Market & Price

Market Cap

$2.71B

Current Price

$21.51

High / Low (52W)

$26.40 / $18.86

Beta

0.97

Valuation

Stock P/E

126.53

Industry PE

23.65

Forward P/E

19.75

PEG Ratio

Book Value

$5.99

Price to Book

3.59

P/S

1.21

EV/EBITDA

49.30

Dividend Yield

Profitability & Returns

ROCE

4.27%

ROE

3.62%

ROA

1.75%

Profit Margin

0.97%

Op Margin

1.23%

EPS (Latest Qtr)

$0.02

EPS (TTM)

$0.17

Balance Sheet & Liquidity

Debt/Equity

1.12

Quick Ratio

1.55

Current Ratio

1.61

Debt

$9.02M

Total Assets

$1.37B

Current Assets

$911.00M

Working Capital

$342.48M

Ownership

Promoter Holding

6.30%

Chg in Prom Hold

FII / Inst Holding

97.37%

Chg in FII Hold

-0.00%

Financial Snapshot

Enterprise Value

$2.35B

Total Revenue (TTM)

$2.25B

EBITDA

$47.73M

Free Cash Flow

$110.66M

Operating Cash Flow

$138.00M

Shares Outstanding

126.01M

Gross Margin

9.97%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

16.10%

Profit 5Y

122.32%

Revenue (YoY)

25.80%

Earnings (YoY)

-33.30%

PROS

Compounding revenue at 16.1% over 5 years.
Profit CAGR of 122.3% over 5 years.
Generates positive free cash flow.

CONS

Trading at a high P/E of 126.5.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	PRVA Privia Health Group, Inc. R2K	21.51	126.53	$2.71B	-	4.27%	3.62%	16.10%	122.32%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	212.94M	183.26M	207.17M	213.61M	225.76M	251.52M	313.80M	335.54M	342.90M	386.28M	413.35M	417.28M	415.24M	422.33M	-	480.10M	521.15M	580.42M	541.17M	603.85M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	434.33M	470.91M	516.65M	491.52M	543.54M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	45.76M	50.24M	63.77M	49.66M	60.31M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	40.54M	46.91M	49.37M	38.38M	52.89M
Operating Income	6.50M	6.18M	8.54M	7.91M	-193.19M	-12.81M	-11.55M	-5.25M	-4.57M	6.71M	6.98M	5.54M	823.00K	5.10M	-	5.22M	3.34M	14.40M	11.28M	7.42M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7.12M	5.92M	17.17M	13.94M	10.70M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.15M	5.74M	16.67M	13.37M	9.31M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.10M	2.46M	6.87M	2.79M	5.60M
Net Income	5.41M	5.28M	16.68M	5.40M	-172.53M	-9.12M	-17.51M	-10.47M	1.62M	7.32M	7.27M	5.64M	2.98M	3.47M	-	4.22M	2.69M	6.86M	9.15M	3.06M
Diluted EPS	0.06	0.06	0.17	0.06	-1.68	-0.09	-0.16	-0.10	0.01	0.06	0.06	0.05	0.02	0.03	-	0.03	0.02	0.05	0.07	0.02

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	786.36M	817.08M	-	1.36B	1.66B	1.74B	2.12B
Cost of Revenue	-	-	-	1.22B	1.50B	1.56B	1.91B
Gross Profit	-	-	-	134.78M	161.50M	176.85M	209.43M
Operating Expenses	-	-	-	153.90M	140.85M	159.87M	175.19M
Operating Income	16.06M	25.38M	-	-19.12M	20.65M	16.98M	34.23M
EBITDA	-	-	-	-14.55M	27.18M	24.25M	44.14M
Interest Expense	-	-	1.07M	-	-	-	-
Pretax Income	-	-	-	-18.58M	29.02M	27.87M	43.94M
Tax Provision	-	-	-	-6.52M	7.99M	10.83M	14.21M
Net Income	8.24M	31.24M	-	-8.59M	23.08M	14.38M	22.92M
Diluted EPS	0.09	0.33	-	-0.08	0.19	0.11	0.19

Compounded Sales Growth

5 Years:	16.10%
1 Year:	25.80%

Compounded Profit Growth

5 Years:	122.32%
1 Year:	-33.30%

Stock Price Performance

1 Year:	-5.49%
6 Months:	-12.42%
3 Months:	-9.43%
1 Month:	-12.88%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	328.97M	-	792.81M	999.90M	1.14B	1.37B
Current Assets	-	-	-	-	551.96M	700.80M	834.82M	911.00M
Cash & Equivalents	-	-	84.63M	-	347.99M	389.51M	491.15M	479.69M
Inventory	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	189.60M	290.77M	316.18M	400.90M
Total Liabilities	-	-	185.32M	-	273.76M	392.51M	452.34M	578.43M
Current Liabilities	-	-	146.94M	-	264.27M	386.95M	449.15M	568.52M
Long Term Debt	-	-	-	31.69M	-	-	-	-
Total Debt	-	-	-	-	11.50M	8.29M	5.59M	9.53M
Total Equity	86.04M	107.46M	146.75M	-	499.09M	561.44M	635.18M	737.22M
Shares Outstanding	-	-	-	-	114.69M	118.22M	120.31M	123.60M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	24.36M	38.89M	-	47.20M	80.78M	109.28M	163.40M
Investing Cash Flow	-5.71M	-380.00K	-	-104.00K	-42.97M	-11.98M	-181.57M
Financing Cash Flow	-10.87M	-767.00K	-	-19.68M	3.71M	4.33M	6.70M
Capital Expenditure	-5.71M	-380.00K	-547.00K	-104.00K	-113.00K	-	-
Free Cash Flow	18.65M	38.51M	-	47.20M	80.78M	109.28M	163.40M
Net Change in Cash	-	-	-	27.41M	41.52M	101.64M	-11.46M

Ratios (Annual)

Figures in %.

Metric	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	9.9%	9.7%	10.2%	9.9%
Operating Margin %	2.0%	3.1%	-	-1.4%	1.2%	1.0%	1.6%
Net Margin %	1.0%	3.8%	-	-0.6%	1.4%	0.8%	1.1%
ROE %	7.7%	21.3%	-	-1.7%	4.1%	2.3%	3.1%
ROCE %	-	13.9%	-	-3.6%	3.4%	2.5%	4.3%

Shareholding Pattern

Insiders

6.30%

Institutions

97.37%

Public Float

103.92%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	15.12%	19.06M	$409.94M
2	FMR, LLC	10.35%	13.05M	$280.61M
3	Durable Capital Partners Lp	9.59%	12.09M	$260.01M
4	Vanguard Portfolio Management LLC	4.98%	6.28M	$135.12M
5	Rubicon Founders LLC	4.72%	5.95M	$127.96M
6	Vanguard Capital Management LLC	3.97%	5.01M	$107.74M
7	State Street Corporation	3.56%	4.49M	$96.58M
8	Van Berkom & Associates Inc.	3.22%	4.05M	$87.18M
9	Riverbridge Partners LLC	3.11%	3.92M	$84.28M
10	Bank Of New York Mellon Corporation	2.34%	2.94M	$63.31M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for PRVA

No recent headlines available.

PRVA · Healthcare